Efficacy of an eConsult Service to Cure Hepatitis C in Primary Care

Jacey Nishiguchi; Anusha McNamara; Colleen S. Surlyn; Kellene Vokaty Eagen; Laura Feeney; Vivian Lian; David E. Smith


J Viral Hepat. 2022;29(1):21-25. 

In This Article


Overall, our study did not find a significant difference in SVR12 rate between patients treated through the eConsult and those treated without use of an eConsult. This suggests the clinical recommendations provided through the eConsult to providers who requested assistance in HCV treatment resulted in similar cure rates as providers who chose to treat independently. There are likely more patient-level factors rather than provider-level factors therefore that drive cure rates. Our study also demonstrated a high overall rate of 97.6% achieving SVR12 in the PP population. In addition to high cure rates, another goal of the eConsult system was to improve provider knowledge and expand training to more providers to increase patient access to treatment. The 40% of patients who were treated through the eConsult service may not have been treated otherwise, which is consistent with prior findings that this service greatly expands access to treatment within our patient population.[8] Expansion of services and treatment access in combination with the high rate of SVR12 demonstrated in our study will help to eliminate HCV in our patient population. This study demonstrates that the implementation of an electronic consultation system aimed to support PCPs to treat HCV without requiring speciality involvement in care is an effective intervention to cure HCV within a large urban safety net health system.